Medical Care

Global Rare Hemophilia Factors Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Rare Hemophilia Factors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rare Hemophilia Factors.
The Rare Hemophilia Factors market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rare Hemophilia Factors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rare Hemophilia Factors companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Biogen
Bayer healthcare
Pfizer, Inc.
Baxalta
CSL Behring
Bio Products Laboratory Ltd.
Segment by Type
Factor I
Factor II
Factor V
Factor VII
Factor X
Factor XI
Factor XIII
Segment by Application
Factor Concentrates
Fresh Frozen Plasma
Cryoprecipitate
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rare Hemophilia Factors company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rare Hemophilia Factors Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Factor I
1.2.3 Factor II
1.2.4 Factor V
1.2.5 Factor VII
1.2.6 Factor X
1.2.7 Factor XI
1.2.8 Factor XIII
1.3 Market by Application
1.3.1 Global Rare Hemophilia Factors Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Factor Concentrates
1.3.3 Fresh Frozen Plasma
1.3.4 Cryoprecipitate
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rare Hemophilia Factors Market Perspective (2020-2031)
2.2 Global Rare Hemophilia Factors Growth Trends by Region
2.2.1 Global Rare Hemophilia Factors Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Rare Hemophilia Factors Historic Market Size by Region (2020-2025)
2.2.3 Rare Hemophilia Factors Forecasted Market Size by Region (2026-2031)
2.3 Rare Hemophilia Factors Market Dynamics
2.3.1 Rare Hemophilia Factors Industry Trends
2.3.2 Rare Hemophilia Factors Market Drivers
2.3.3 Rare Hemophilia Factors Market Challenges
2.3.4 Rare Hemophilia Factors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rare Hemophilia Factors Players by Revenue
3.1.1 Global Top Rare Hemophilia Factors Players by Revenue (2020-2025)
3.1.2 Global Rare Hemophilia Factors Revenue Market Share by Players (2020-2025)
3.2 Global Rare Hemophilia Factors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Rare Hemophilia Factors Revenue
3.4 Global Rare Hemophilia Factors Market Concentration Ratio
3.4.1 Global Rare Hemophilia Factors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rare Hemophilia Factors Revenue in 2024
3.5 Global Key Players of Rare Hemophilia Factors Head office and Area Served
3.6 Global Key Players of Rare Hemophilia Factors, Product and Application
3.7 Global Key Players of Rare Hemophilia Factors, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Rare Hemophilia Factors Breakdown Data by Type
4.1 Global Rare Hemophilia Factors Historic Market Size by Type (2020-2025)
4.2 Global Rare Hemophilia Factors Forecasted Market Size by Type (2026-2031)
5 Rare Hemophilia Factors Breakdown Data by Application
5.1 Global Rare Hemophilia Factors Historic Market Size by Application (2020-2025)
5.2 Global Rare Hemophilia Factors Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Rare Hemophilia Factors Market Size (2020-2031)
6.2 North America Rare Hemophilia Factors Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Rare Hemophilia Factors Market Size by Country (2020-2025)
6.4 North America Rare Hemophilia Factors Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rare Hemophilia Factors Market Size (2020-2031)
7.2 Europe Rare Hemophilia Factors Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Rare Hemophilia Factors Market Size by Country (2020-2025)
7.4 Europe Rare Hemophilia Factors Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rare Hemophilia Factors Market Size (2020-2031)
8.2 Asia-Pacific Rare Hemophilia Factors Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Rare Hemophilia Factors Market Size by Region (2020-2025)
8.4 Asia-Pacific Rare Hemophilia Factors Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rare Hemophilia Factors Market Size (2020-2031)
9.2 Latin America Rare Hemophilia Factors Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Rare Hemophilia Factors Market Size by Country (2020-2025)
9.4 Latin America Rare Hemophilia Factors Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rare Hemophilia Factors Market Size (2020-2031)
10.2 Middle East & Africa Rare Hemophilia Factors Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Rare Hemophilia Factors Market Size by Country (2020-2025)
10.4 Middle East & Africa Rare Hemophilia Factors Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Rare Hemophilia Factors Introduction
11.1.4 Novo Nordisk Revenue in Rare Hemophilia Factors Business (2020-2025)
11.1.5 Novo Nordisk Recent Development
11.2 Biogen
11.2.1 Biogen Company Details
11.2.2 Biogen Business Overview
11.2.3 Biogen Rare Hemophilia Factors Introduction
11.2.4 Biogen Revenue in Rare Hemophilia Factors Business (2020-2025)
11.2.5 Biogen Recent Development
11.3 Bayer healthcare
11.3.1 Bayer healthcare Company Details
11.3.2 Bayer healthcare Business Overview
11.3.3 Bayer healthcare Rare Hemophilia Factors Introduction
11.3.4 Bayer healthcare Revenue in Rare Hemophilia Factors Business (2020-2025)
11.3.5 Bayer healthcare Recent Development
11.4 Pfizer, Inc.
11.4.1 Pfizer, Inc. Company Details
11.4.2 Pfizer, Inc. Business Overview
11.4.3 Pfizer, Inc. Rare Hemophilia Factors Introduction
11.4.4 Pfizer, Inc. Revenue in Rare Hemophilia Factors Business (2020-2025)
11.4.5 Pfizer, Inc. Recent Development
11.5 Baxalta
11.5.1 Baxalta Company Details
11.5.2 Baxalta Business Overview
11.5.3 Baxalta Rare Hemophilia Factors Introduction
11.5.4 Baxalta Revenue in Rare Hemophilia Factors Business (2020-2025)
11.5.5 Baxalta Recent Development
11.6 CSL Behring
11.6.1 CSL Behring Company Details
11.6.2 CSL Behring Business Overview
11.6.3 CSL Behring Rare Hemophilia Factors Introduction
11.6.4 CSL Behring Revenue in Rare Hemophilia Factors Business (2020-2025)
11.6.5 CSL Behring Recent Development
11.7 Bio Products Laboratory Ltd.
11.7.1 Bio Products Laboratory Ltd. Company Details
11.7.2 Bio Products Laboratory Ltd. Business Overview
11.7.3 Bio Products Laboratory Ltd. Rare Hemophilia Factors Introduction
11.7.4 Bio Products Laboratory Ltd. Revenue in Rare Hemophilia Factors Business (2020-2025)
11.7.5 Bio Products Laboratory Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Rare Hemophilia Factors Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Factor I
Table 3. Key Players of Factor II
Table 4. Key Players of Factor V
Table 5. Key Players of Factor VII
Table 6. Key Players of Factor X
Table 7. Key Players of Factor XI
Table 8. Key Players of Factor XIII
Table 9. Global Rare Hemophilia Factors Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Rare Hemophilia Factors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Rare Hemophilia Factors Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Rare Hemophilia Factors Market Share by Region (2020-2025)
Table 13. Global Rare Hemophilia Factors Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Rare Hemophilia Factors Market Share by Region (2026-2031)
Table 15. Rare Hemophilia Factors Market Trends
Table 16. Rare Hemophilia Factors Market Drivers
Table 17. Rare Hemophilia Factors Market Challenges
Table 18. Rare Hemophilia Factors Market Restraints
Table 19. Global Rare Hemophilia Factors Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Rare Hemophilia Factors Market Share by Players (2020-2025)
Table 21. Global Top Rare Hemophilia Factors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Hemophilia Factors as of 2024)
Table 22. Ranking of Global Top Rare Hemophilia Factors Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Rare Hemophilia Factors Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Rare Hemophilia Factors, Headquarters and Area Served
Table 25. Global Key Players of Rare Hemophilia Factors, Product and Application
Table 26. Global Key Players of Rare Hemophilia Factors, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Rare Hemophilia Factors Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Rare Hemophilia Factors Revenue Market Share by Type (2020-2025)
Table 30. Global Rare Hemophilia Factors Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Rare Hemophilia Factors Revenue Market Share by Type (2026-2031)
Table 32. Global Rare Hemophilia Factors Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Rare Hemophilia Factors Revenue Market Share by Application (2020-2025)
Table 34. Global Rare Hemophilia Factors Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Rare Hemophilia Factors Revenue Market Share by Application (2026-2031)
Table 36. North America Rare Hemophilia Factors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Rare Hemophilia Factors Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Rare Hemophilia Factors Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Rare Hemophilia Factors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Rare Hemophilia Factors Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Rare Hemophilia Factors Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Rare Hemophilia Factors Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Rare Hemophilia Factors Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Rare Hemophilia Factors Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Rare Hemophilia Factors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Rare Hemophilia Factors Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Rare Hemophilia Factors Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Rare Hemophilia Factors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Rare Hemophilia Factors Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Rare Hemophilia Factors Market Size by Country (2026-2031) & (US$ Million)
Table 51. Novo Nordisk Company Details
Table 52. Novo Nordisk Business Overview
Table 53. Novo Nordisk Rare Hemophilia Factors Product
Table 54. Novo Nordisk Revenue in Rare Hemophilia Factors Business (2020-2025) & (US$ Million)
Table 55. Novo Nordisk Recent Development
Table 56. Biogen Company Details
Table 57. Biogen Business Overview
Table 58. Biogen Rare Hemophilia Factors Product
Table 59. Biogen Revenue in Rare Hemophilia Factors Business (2020-2025) & (US$ Million)
Table 60. Biogen Recent Development
Table 61. Bayer healthcare Company Details
Table 62. Bayer healthcare Business Overview
Table 63. Bayer healthcare Rare Hemophilia Factors Product
Table 64. Bayer healthcare Revenue in Rare Hemophilia Factors Business (2020-2025) & (US$ Million)
Table 65. Bayer healthcare Recent Development
Table 66. Pfizer, Inc. Company Details
Table 67. Pfizer, Inc. Business Overview
Table 68. Pfizer, Inc. Rare Hemophilia Factors Product
Table 69. Pfizer, Inc. Revenue in Rare Hemophilia Factors Business (2020-2025) & (US$ Million)
Table 70. Pfizer, Inc. Recent Development
Table 71. Baxalta Company Details
Table 72. Baxalta Business Overview
Table 73. Baxalta Rare Hemophilia Factors Product
Table 74. Baxalta Revenue in Rare Hemophilia Factors Business (2020-2025) & (US$ Million)
Table 75. Baxalta Recent Development
Table 76. CSL Behring Company Details
Table 77. CSL Behring Business Overview
Table 78. CSL Behring Rare Hemophilia Factors Product
Table 79. CSL Behring Revenue in Rare Hemophilia Factors Business (2020-2025) & (US$ Million)
Table 80. CSL Behring Recent Development
Table 81. Bio Products Laboratory Ltd. Company Details
Table 82. Bio Products Laboratory Ltd. Business Overview
Table 83. Bio Products Laboratory Ltd. Rare Hemophilia Factors Product
Table 84. Bio Products Laboratory Ltd. Revenue in Rare Hemophilia Factors Business (2020-2025) & (US$ Million)
Table 85. Bio Products Laboratory Ltd. Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 89. Authors List of This Report


List of Figures
Figure 1. Rare Hemophilia Factors Picture
Figure 2. Global Rare Hemophilia Factors Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Rare Hemophilia Factors Market Share by Type: 2024 VS 2031
Figure 4. Factor I Features
Figure 5. Factor II Features
Figure 6. Factor V Features
Figure 7. Factor VII Features
Figure 8. Factor X Features
Figure 9. Factor XI Features
Figure 10. Factor XIII Features
Figure 11. Global Rare Hemophilia Factors Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Rare Hemophilia Factors Market Share by Application: 2024 VS 2031
Figure 13. Factor Concentrates Case Studies
Figure 14. Fresh Frozen Plasma Case Studies
Figure 15. Cryoprecipitate Case Studies
Figure 16. Others Case Studies
Figure 17. Rare Hemophilia Factors Report Years Considered
Figure 18. Global Rare Hemophilia Factors Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Rare Hemophilia Factors Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Rare Hemophilia Factors Market Share by Region: 2024 VS 2031
Figure 21. Global Rare Hemophilia Factors Market Share by Players in 2024
Figure 22. Global Top Rare Hemophilia Factors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Hemophilia Factors as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Rare Hemophilia Factors Revenue in 2024
Figure 24. North America Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Rare Hemophilia Factors Market Share by Country (2020-2031)
Figure 26. United States Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Rare Hemophilia Factors Market Share by Country (2020-2031)
Figure 30. Germany Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Rare Hemophilia Factors Market Share by Region (2020-2031)
Figure 38. China Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Rare Hemophilia Factors Market Share by Country (2020-2031)
Figure 46. Mexico Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Rare Hemophilia Factors Market Share by Country (2020-2031)
Figure 50. Turkey Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Rare Hemophilia Factors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Novo Nordisk Revenue Growth Rate in Rare Hemophilia Factors Business (2020-2025)
Figure 54. Biogen Revenue Growth Rate in Rare Hemophilia Factors Business (2020-2025)
Figure 55. Bayer healthcare Revenue Growth Rate in Rare Hemophilia Factors Business (2020-2025)
Figure 56. Pfizer, Inc. Revenue Growth Rate in Rare Hemophilia Factors Business (2020-2025)
Figure 57. Baxalta Revenue Growth Rate in Rare Hemophilia Factors Business (2020-2025)
Figure 58. CSL Behring Revenue Growth Rate in Rare Hemophilia Factors Business (2020-2025)
Figure 59. Bio Products Laboratory Ltd. Revenue Growth Rate in Rare Hemophilia Factors Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies